Cva Family Office, LLC Seagen Inc. Transaction History

Cva Family Office, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$108.81 - $179.33 $3,808 - $6,276	35 Added 233.33%	50 $9,000
Q1 2022 Apr 22, 2022	SELL	$119.61 - $157.85 $1,794 - $2,367	-15 Reduced 50.0%	15 $2,000
Q4 2021 Jan 25, 2022	BUY	$142.57 - $190.86 $4,277 - $5,725	30 New	30 $5,000
Q3 2021 Oct 12, 2021	SELL	$142.45 - $169.82 $14,244 - $16,982	-100 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$135.08 - $161.1 $12,832 - $15,304	95 Added 1900.0%	100 $16,000
Q1 2021 Apr 14, 2021	BUY	$137.51 - $190.8 $687 - $954	5 New	5 $1,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.